MiR-103a-3p is recently reported to be related to AD progression via regulating NPAS3 expression [96], while low level of miR-181c-5p in serum is suggested to be an indicator for cerebral vulnerability in AD [97]. Here, NPAS3 is linked to Alzheimer disease.